These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 20673554

  • 1. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    Calabrese JR, Ketter TA, Youakim JM, Tiller JM, Yang R, Frye MA.
    J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.
    Calabrese JR, Frye MA, Yang R, Ketter TA, Armodafinil Treatment Trial Study Network.
    J Clin Psychiatry; 2014 Oct; 75(10):1054-61. PubMed ID: 25099397
    [Abstract] [Full Text] [Related]

  • 3. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder.
    Ketter TA, Yang R, Frye MA.
    J Affect Disord; 2015 Aug 01; 181():87-91. PubMed ID: 25933099
    [Abstract] [Full Text] [Related]

  • 4. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM, D'Souza DC, Patkar AA, Youakim JM, Tiller JM, Yang R, Keefe RS.
    J Clin Psychiatry; 2010 Nov 01; 71(11):1475-81. PubMed ID: 20816042
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov 01; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 6. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH.
    J Clin Psychiatry; 2013 Nov 01; 74(11):1101-7. PubMed ID: 24330897
    [Abstract] [Full Text] [Related]

  • 7. Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments.
    Frye MA, Amchin J, Bauer M, Adler C, Yang R, Ketter TA.
    Int J Bipolar Disord; 2015 Dec 01; 3(1):34. PubMed ID: 26330288
    [Abstract] [Full Text] [Related]

  • 8. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul 01; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan 01; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 10. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.
    J Clin Psychiatry; 2010 Feb 01; 71(2):130-7. PubMed ID: 20122373
    [Abstract] [Full Text] [Related]

  • 11. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Feb 01; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B.
    J Clin Psychiatry; 2011 Oct 01; 72(10):1413-22. PubMed ID: 21672493
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR, Clinical Affairs Product Support Study-168 Investigators.
    J Clin Psychiatry; 2006 Nov 01; 67(11):1698-706. PubMed ID: 17196048
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov 01; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study.
    Ketter TA, Amchin J, Frye MA, Gross N.
    J Affect Disord; 2016 Jun 01; 197():51-7. PubMed ID: 26970266
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb 01; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2002 Jan 01; 59(1):62-9. PubMed ID: 11779284
    [Abstract] [Full Text] [Related]

  • 18. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun 01; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA, Tamburri P, Deptula D, Banken L, Beyer U, Rabbia M, Parkar N, Fontoura P, Santarelli L.
    JAMA Psychiatry; 2016 Jul 01; 73(7):675-84. PubMed ID: 27304433
    [Abstract] [Full Text] [Related]

  • 20. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR.
    Am J Psychiatry; 2014 Feb 01; 171(2):169-77. PubMed ID: 24170221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.